Management of Chronic Pain with Duloxetine and Venlafaxine

Risks of Duloxetine-Venlafaxine Combination

The American Academy of Child and Adolescent Psychiatry recommends avoiding the combination of duloxetine and venlafaxine due to the high risk of serotonin syndrome and other additive adverse effects 1, 2
The concomitant administration of two serotonin-norepinephrine reuptake inhibitors (SNRIs) significantly increases the risk of serotonin syndrome, a potentially severe condition 2
Both medications can cause cardiovascular effects, including increased blood pressure and cardiac conduction abnormalities 3, 4

The American Academy of Neurology recommends gabapentine or prégabaline as first-line treatments for neuropathic pain, with minimal drug interactions with venlafaxine 3, 5
Gabapentine can be initiated at 100-300 mg at bedtime or 100-300 mg three times a day, with gradual increase 6
Prégabaline can be initiated at 50 mg three times a day or 75 mg twice a day 6
Lidocaïne topique is effective for localized peripheral pain without significant systemic interactions 3
Tramadol can be considered for short-term pain relief, starting at 50 mg one to two times a day, up to 400 mg per day 5
Opioïdes can be used as a third-line treatment for severe uncontrolled pain, using the smallest effective dose 7

Close monitoring of serotonin syndrome signs (agitation, hallucinations, tachycardia, hyperthermia, hyperreflexia, altered coordination) is essential when using duloxetine with venlafaxine 2
Regular blood pressure and pulse checks are necessary 4, 8
Monitoring for abnormal bleeding symptoms is recommended due to increased risk 2
Hepatotoxicity signs (abdominal pain, jaundice) should be monitored when using duloxetine 2